Copy
CTT Pharmaceutical Holdings, Inc. Approved by SEC to Become Reporting Company
August 5, 2026 — Leads & Copy — CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) announced it has received formal approval from the U.S. Securities and Exchange Commission (SEC) for its S-1 filing, officially becoming an SEC reporting company. This significant milestone means CTT Pharma is now an audited, SEC reporting entity on the OTCQB market. The company will now file SEC Form 8-K for material events and will provide further updates to shareholders as more information becomes available.
CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company that develops oral drug delivery systems. These systems are designed for rapid onset, increased patient convenience, and improved absorption. The company's patented micelle-based thin film platform offers a new alternative to conventional dosage forms for use in pharmaceutical, therapeutic, and nutraceutical markets.
The company focuses on combining scientific validation, manufacturing scalability, and regulatory readiness to foster sustained growth and product innovation. CTT Pharmaceutical Holdings, Inc. can be reached at 813-606-0060.